J&J offers to pay₹25 lakh each to 67 patients’ faulty hip implants

1. US pharmaceutical company Johnson & Johnson (J&J) Pvt Ltd has agreed to pay 25 lakhs to 67 patients affected by its faulty acetabular surface replacement (ASR) hip implants. Earlier,in May Delhi High Court directed it to pay ₹25 lakh each to 4 patients affected by its faulty hip implants. 2. Central Drugs Standard Control… Continue reading J&J offers to pay₹25 lakh each to 67 patients’ faulty hip implants

Submit report on any adverse reaction to pelvic mesh, J&J told

The Indian government has written to US based pharmaceutical company Johnson & Johnson to furnish details of the number of surgical pelvic meshes it has imported into India in the last three years. The government’s move comes in the backdrop of the U.S Food and Drug Administration(FDA) banning the transvaginal pelvic mesh after women have… Continue reading Submit report on any adverse reaction to pelvic mesh, J&J told

After J&J case, govt. treads carefully

The Drugs Technical Advisory Board (DTAB) has recommended amendment to Rule 26 of the Drugs and Cosmetics Rules,1945,which deals with conditions under import licences. The proposed amendment makes it mandatory for import license holders to maintain control samples of imported drugs.In case of drugs bearing an expiry date on the label,the reference samples shall be… Continue reading After J&J case, govt. treads carefully

J&J baby care products: NCPCR summons officials of five states

The National Commission for the Protection of Child Rights (NCPCR) has summoned senior state government officials from five states to update on the steps taken on safety issues regarding the use of Johnson & Johnson(J&J) baby care products. Recently,NCPCR had received a private complaint stating that objectionable contents have been found in the shampoo samples… Continue reading J&J baby care products: NCPCR summons officials of five states

Johnson & Johnson told to pay compensation

Central Drugs Standard Control Organisation (CDSCO) has ordered Johnson and Johnson to pay compensation to the first patient who received faulty hip implants made by the firm. Earlier,Government had set up a committee which provided details about the faulty hip prosthetics sold by a subsidiary of the U.S. firm Johnson & Johnson to Indian patients.It… Continue reading Johnson & Johnson told to pay compensation